FDA approval


Perrigo Confirms FDA Approval For Testosterone Gel 1%

Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo’s NDA included a bioequivalence study that compared its product to AbbVie’s AndroGel 1%.

WWJ Newsradio 950–02/06/2013

Stem Cell research at U of M may help patients with Lou Gehrig's disease. (File Photo)

Stem Cell Research Aims To Help Lou Gehrig’s Patients

Promising new research at the University of Michigan that could bring new hope to those suffering from Lou Gehrig’s disease.

WWJ Newsradio 950–05/16/2011

Perrigo Gets FDA Approval for OTC Allergy Syrup

Allegan-based Perrrigo Co. (Nasdaq: PRGO) said Monday that it has received final approval from the United States Food and Drug Administration to manufacture and market over-the-counter Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the […]